Definice Amgen Group

Amgen Group means Amgen Inc. and its affiliates and
Amgen Group means Amgen Inc. and its affiliates and subsidiaries. 1.4 „Amgen Inc.“ znamená akciovou společnost Amgen Inc. založenou ve státě Delaware, USA, s hlavním místem podnikání na adrese One Xxxxx Xxxxxx Xxxxx, Xxxxxxxx Xxxx, Xxxxxxxxxx, 00000-0000, XXX. 1.4 “Amgen Inc.” shall mean the Delaware, USA corporation called Amgen Inc. having a principal place of business at Xxx Xxxxx Xxxxxx Xxxxx, Xxxxxxxx Xxxx, Xxxxxxxxxx, 00000-0000 U.S.A. 1.5 „GMP - správná výrobní praxe“ znamená ustanovení týkající se výrobní činnosti, jak jsou obsažena ve Směrnici Evropského parlamentu a Rady 2001/83/ES ze dne 6. listopadu 2001 o kodexu Společenství týkajícím se humánních léčivých přípravků, ve Směrnici Komise 2003/94/ES ze dne 8. října 2003, kterou se stanoví zásady a pokyny pro správnou výrobní praxi pro humánní léčivé přípravky a hodnocené humánní léčivé přípravky, jakákoli národní ustanovení zavádějící výše uvedené směrnice na Území a Pokyny EU týkající se správné výrobní praxe u léčivých přípravků pro humánní a veterinární použití obsažené ve svazku iv zásad pro léčivé přípravky v EU, ve znění pozdějších předpisů. 1.5 “GMP” means the provisions relating to manufacturing activities contained in Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use, Commission Directive 2003/94/EC of 8 October 2003, laying down the principles and guidelines of good manufacturing practice in respect of medicinal products for human use and investigational medicinal products for human use, any national provisions implementing the aforementioned directives in the Territory and the EU Guidelines concerning good manufacturing practice for medicinal products for human and veterinary use contained in volume iv of the rules governing medicinal products in the EU as amended from time to time. 1.6 „Platební neschopnost“ znamená jakoukoli událost, která nastane a kdy Kupující (i) se ocitne v platební neschopnosti nebo vstoupí do likvidace, (ii) požaduje konkurz, restrukturalizaci, 1.6 “Insolvency Event” means any event to occur where Buyer (i) is insolvent or goes into liquidation, (ii) requests, or is the subject of, any bankruptcy, reorganization, dissolution, winding-up or similar rozpuštění, zrušení nebo podobné řízení nebo je na něj vyhlášen konkurz či uvalena restrukturalizace, rozpuštění, zrušení nebo podobné řízení, případně je mu jmenován nucený správce nebo správce konkurzní podstaty, (iii) uzavře ...
Amgen Group means Amgen Inc. and its affiliates and subsidiaries. 1.4 “Amgen Inc.” shall mean the Delaware, USA corporation called Amgen Inc. having a principal place of business at Xxx Xxxxx Xxxxxx Xxxxx, Xxxxxxxx Xxxx, Xxxxxxxxxx, 00000-0000 U.S.A. 1.5 “GMP” means the provisions relating to manufacturing activities contained in Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use, Commission Directive 2003/94/EC of 8 October 2003, laying down the principles and guidelines of good manufacturing practice in respect of medicinal products for human use and investigational medicinal products for human use, any national provisions implementing the aforementioned directives in the Territory and the EU

Examples of Amgen Group in a sentence

  • All intellectual property rights shall be exclusively owned by Amgen Inc (or its designated Amgen Group member).

  • In no event shall Buyer, unless duly authorized, act in any way whatsoever as agent for Amgen, to represent Amgen, pledge Amgen’s credit, enter into any contract or undertaking of any sort, make any promise, warranty or representation on behalf of Amgen (or any other Amgen Group member) or settle any claim or express any opinion on behalf of Amgen (or any other Amgen Group member) as to the merit of such claim with respect to the Products or any related matter.

  • Buyer will not make any press release, statement or public announcement that in any way mentions or refers to any Amgen Group member without Xxxxx’x prior written consent.

  • In addition the reimbursement of all costs incurred by Amgen or any Amgen Group member due to late payment shall be paid, provided, however, that such amount shall not exceed the maximum amount permitted by applicable law.

  • Amgen shall have the right to use any Amgen Group member to act as Xxxxx’x representative for the performance of any obligation arising under this Agreement.

  • Buyer shall indemnify, defend and hold harmless Amgen (including any Amgen Group member) from and against any claims, costs, expenses and damages arising out of any abnormal or improper use, misuse or neglect of the Products, including without limitation storage of the Products other than in accordance with the Package Leaflet, and for any breach of this Agreement.

  • Amgen shall have the right to use any Amgen Group member to act as Amgen’s representative for the performance of any obligation arising under this Agreement.

  • Buyer shall cooperate with Amgen in the case of any recall of Products, including providing full support to deliver requested information to Amgen and any designated Amgen Group member (e.g. track trace reports) and in taking all necessary steps to remove the relevant batch from the market place at Amgen’s cost.

  • Each party shall indemnify, defend and hold harmless the other party (including any Amgen Group member or Buyer Group member) from and against any claims, costs, expenses and damages arising out of the breach of this Article.

  • Buyer will not make any press release, statement or public announcement that in any way mentions or refers to any Amgen Group member without Amgen’s prior written consent.

Related to Amgen Group

  • CDCP “ je společnost Centrální depozitář cenných papírů, a.s. se sídlem Praha 1, Rybná 14, PSČ: 110 00, IČ 250 81 489, zapsaná v obchodním rejstříku vedeném Městským soudem v Praze, oddíl B, vložka 4308.